WO2008032665A1 - Nouveau dérivé de l'acide phénylacétique - Google Patents
Nouveau dérivé de l'acide phénylacétique Download PDFInfo
- Publication number
- WO2008032665A1 WO2008032665A1 PCT/JP2007/067568 JP2007067568W WO2008032665A1 WO 2008032665 A1 WO2008032665 A1 WO 2008032665A1 JP 2007067568 W JP2007067568 W JP 2007067568W WO 2008032665 A1 WO2008032665 A1 WO 2008032665A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- hydrogen atom
- acid
- atom
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
Description
Claims
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/440,540 US8148421B2 (en) | 2006-09-11 | 2007-09-10 | Phenylacetic acid derivative |
BRPI0716550-1A2A BRPI0716550A2 (pt) | 2006-09-11 | 2007-09-10 | derivativo original de Ácido fenilacÉtico |
KR1020097007100A KR101360579B1 (ko) | 2006-09-11 | 2007-09-10 | 신규 페닐초산 유도체 |
MX2009002692A MX2009002692A (es) | 2006-09-11 | 2007-09-10 | Derivado de acido fenilacetico novedoso. |
IN1906CHN2009 IN2009CN01906A (ja) | 2006-09-11 | 2007-09-10 | |
AU2007295510A AU2007295510B2 (en) | 2006-09-11 | 2007-09-10 | Novel phenylacetic acid derivative |
ES07828211T ES2402377T3 (es) | 2006-09-11 | 2007-09-10 | Derivados del ácido fenilacético y composición farmacéutica de los mismos |
NZ575635A NZ575635A (en) | 2006-09-11 | 2007-09-10 | Novel Phenylacetic Acid derivatives having suppressing action against prostaglandin E2 production and useful in medicaments of reduced adverse reactions such as gastrointestinal disorders. |
CN2007800337348A CN101535289B (zh) | 2006-09-11 | 2007-09-10 | 苯乙酸衍生物 |
JP2008534321A JP4538072B2 (ja) | 2006-09-11 | 2007-09-10 | 新規フェニル酢酸誘導体 |
EP07828211A EP2062884B1 (en) | 2006-09-11 | 2007-09-10 | Phenylacetic acid derivatives and pharmaceutical composition thereof |
CA2663234A CA2663234C (en) | 2006-09-11 | 2007-09-10 | Novel phenylacetic acid derivative |
IL197506A IL197506A0 (en) | 2006-09-11 | 2009-03-10 | Novel phenylacetic acid derivative |
NO20091419A NO20091419L (no) | 2006-09-11 | 2009-04-07 | Fenyleddiksyrederivat |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006-245194 | 2006-09-11 | ||
JP2006245194 | 2006-09-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008032665A1 true WO2008032665A1 (fr) | 2008-03-20 |
Family
ID=39183724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/067568 WO2008032665A1 (fr) | 2006-09-11 | 2007-09-10 | Nouveau dérivé de l'acide phénylacétique |
Country Status (19)
Country | Link |
---|---|
US (1) | US8148421B2 (ja) |
EP (1) | EP2062884B1 (ja) |
JP (1) | JP4538072B2 (ja) |
KR (1) | KR101360579B1 (ja) |
CN (1) | CN101535289B (ja) |
AR (1) | AR062723A1 (ja) |
AU (1) | AU2007295510B2 (ja) |
BR (1) | BRPI0716550A2 (ja) |
CA (1) | CA2663234C (ja) |
ES (1) | ES2402377T3 (ja) |
IL (1) | IL197506A0 (ja) |
IN (1) | IN2009CN01906A (ja) |
MX (1) | MX2009002692A (ja) |
NO (1) | NO20091419L (ja) |
NZ (1) | NZ575635A (ja) |
RU (1) | RU2414465C2 (ja) |
TW (1) | TW200827343A (ja) |
WO (1) | WO2008032665A1 (ja) |
ZA (1) | ZA200901988B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101704777B (zh) * | 2009-10-18 | 2012-10-31 | 伊泰(北京)合成技术有限公司 | 一种去除前列素类化合物5,6位反式双键异构体的方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116239498B (zh) * | 2023-05-11 | 2023-07-21 | 北京元延医药科技股份有限公司 | 制备克立硼罗中间体的方法 |
CN116253756B (zh) * | 2023-05-11 | 2023-07-18 | 北京元延医药科技股份有限公司 | 克立硼罗的制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5461159A (en) * | 1977-10-21 | 1979-05-17 | Sagami Chem Res Center | Alpha-thio-alpha-(acylphenyl) carboxylic acid derivatives |
JPS5649376A (en) * | 1980-05-08 | 1981-05-02 | Toyama Chem Co Ltd | 2- 4- 3-methyl-2-thienyl phenyl propionic acid and its nontoxic salt |
JPS58105939A (ja) * | 1981-12-18 | 1983-06-24 | Sankyo Co Ltd | 置換フエニル酢酸誘導体及びその製法 |
WO1993002999A1 (en) * | 1991-08-10 | 1993-02-18 | Hisamitsu Pharmaceutical Co., Inc. | Phenylalkanoic acid derivative, production thereof, and separation of optical isomers thereof |
JPH05132478A (ja) * | 1991-11-11 | 1993-05-28 | Hisamitsu Pharmaceut Co Inc | 新規な(1,3−ジチオラン−2−イリデン)メチル フエニルアルカン酸誘導体 |
JP2003531194A (ja) * | 2000-04-24 | 2003-10-21 | メルク フロスト カナダ アンド カンパニー | プロスタグランジンe阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物 |
US20040054008A1 (en) | 2002-09-13 | 2004-03-18 | Tohru Araki | Medicament for treatment of nocturia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161538A (en) * | 1977-04-05 | 1979-07-17 | Sankyo Company Limited | Substituted phenylacetic acid derivatives and process for the preparation thereof |
JPS5432460A (en) * | 1977-08-16 | 1979-03-09 | Sankyo Co Ltd | Cycloalkylidenemethylphenylacetic acid derivative and their preparation |
JPS5481260A (en) | 1977-11-21 | 1979-06-28 | Toyama Chem Co Ltd | 2-4-(3-methyl-2-thienyl)phenyl propionic acid, its nontoxic salt and antiphlogistics, analgesics, and antirheumatics containing them |
AU4481600A (en) | 1999-04-22 | 2000-11-10 | Qode.Com, Inc. | System and method for providing electronic information upon receipt of a scannedbar code |
AU778720B2 (en) | 1999-08-23 | 2004-12-16 | Kyorin Pharmaceutical Co. Ltd. | Substituted benzylthiazolidine-2,4-dione derivatives |
EP1551396A1 (en) | 2002-09-26 | 2005-07-13 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
-
2007
- 2007-09-07 TW TW096133551A patent/TW200827343A/zh unknown
- 2007-09-10 BR BRPI0716550-1A2A patent/BRPI0716550A2/pt not_active IP Right Cessation
- 2007-09-10 CN CN2007800337348A patent/CN101535289B/zh not_active Expired - Fee Related
- 2007-09-10 KR KR1020097007100A patent/KR101360579B1/ko not_active IP Right Cessation
- 2007-09-10 AU AU2007295510A patent/AU2007295510B2/en not_active Ceased
- 2007-09-10 IN IN1906CHN2009 patent/IN2009CN01906A/en unknown
- 2007-09-10 AR ARP070103987A patent/AR062723A1/es not_active Application Discontinuation
- 2007-09-10 WO PCT/JP2007/067568 patent/WO2008032665A1/ja active Application Filing
- 2007-09-10 US US12/440,540 patent/US8148421B2/en not_active Expired - Fee Related
- 2007-09-10 MX MX2009002692A patent/MX2009002692A/es active IP Right Grant
- 2007-09-10 ZA ZA200901988A patent/ZA200901988B/xx unknown
- 2007-09-10 ES ES07828211T patent/ES2402377T3/es active Active
- 2007-09-10 EP EP07828211A patent/EP2062884B1/en active Active
- 2007-09-10 RU RU2009113546/04A patent/RU2414465C2/ru not_active IP Right Cessation
- 2007-09-10 CA CA2663234A patent/CA2663234C/en not_active Expired - Fee Related
- 2007-09-10 NZ NZ575635A patent/NZ575635A/en not_active IP Right Cessation
- 2007-09-10 JP JP2008534321A patent/JP4538072B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-10 IL IL197506A patent/IL197506A0/en unknown
- 2009-04-07 NO NO20091419A patent/NO20091419L/no not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5461159A (en) * | 1977-10-21 | 1979-05-17 | Sagami Chem Res Center | Alpha-thio-alpha-(acylphenyl) carboxylic acid derivatives |
JPS5649376A (en) * | 1980-05-08 | 1981-05-02 | Toyama Chem Co Ltd | 2- 4- 3-methyl-2-thienyl phenyl propionic acid and its nontoxic salt |
JPS58105939A (ja) * | 1981-12-18 | 1983-06-24 | Sankyo Co Ltd | 置換フエニル酢酸誘導体及びその製法 |
WO1993002999A1 (en) * | 1991-08-10 | 1993-02-18 | Hisamitsu Pharmaceutical Co., Inc. | Phenylalkanoic acid derivative, production thereof, and separation of optical isomers thereof |
JPH05132478A (ja) * | 1991-11-11 | 1993-05-28 | Hisamitsu Pharmaceut Co Inc | 新規な(1,3−ジチオラン−2−イリデン)メチル フエニルアルカン酸誘導体 |
JP2003531194A (ja) * | 2000-04-24 | 2003-10-21 | メルク フロスト カナダ アンド カンパニー | プロスタグランジンe阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物 |
US20040054008A1 (en) | 2002-09-13 | 2004-03-18 | Tohru Araki | Medicament for treatment of nocturia |
Non-Patent Citations (21)
Title |
---|
ACTA MEDICA OKAYAMA, vol. 58, 2004, pages 45 - 49 |
BJU INTERNATIONAL, vol. 88, 2000, pages 126 - 127 |
BRITISH MEDICAL JOURNAL, 1980 |
BRITISH MEDICAL JOURNAL, vol. 2, 1980, pages 281 - 282 |
CLINICAL AND EXPERIMENTAL PHARMACOLOGY & PHYSIOLOGY, vol. 13, 1986, pages 139 - 142 |
GREENE; WUTS: "Protective Groups in Organic Synthesis (Third Edition)" |
INTERNATIONAL CONTINENCE SOCIETY (NEUROUROL. URODYN., 2002 |
JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, vol. 35, 2004, pages 175S |
JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003 |
JAPANESE UROLOGICAL ASSOCIATION, 2002 |
JAPANESE UROLOGICAL ASSOCIATION, 2002, pages 585 |
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol. 11, 1983, pages 11 - 17 |
JOURNAL OF JAPANESE UROLOGICAL ASSOCIATION, vol. 93, 2002, pages 394 |
JOURNAL OF UROLOGY, vol. 142, 1989, pages 1290 - 1292 |
NEUROUROL. URODYN., vol. 21, 2002, pages 167 - 178 |
ORGANIC SYNTHESIS, vol. 62, 1984, pages 158 |
OYO YAKURI, APPLIED PHARMACOLOGY, vol. 21, 1981, pages 753 - 771 |
PRESSE MEDICALE, vol. 24, 1995, pages 31 - 34 |
See also references of EP2062884A4 |
SYNTHESIS, vol. 831, 1978 |
YAKURI; CHIRYO, JAPANESE PHARMACOLOGY & THERAPEUTICS, vol. 14, 1986, pages 5191 - 5209 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101704777B (zh) * | 2009-10-18 | 2012-10-31 | 伊泰(北京)合成技术有限公司 | 一种去除前列素类化合物5,6位反式双键异构体的方法 |
Also Published As
Publication number | Publication date |
---|---|
KR101360579B1 (ko) | 2014-02-10 |
JPWO2008032665A1 (ja) | 2010-01-28 |
NO20091419L (no) | 2009-05-20 |
AR062723A1 (es) | 2008-11-26 |
IN2009CN01906A (ja) | 2015-08-07 |
JP4538072B2 (ja) | 2010-09-08 |
ES2402377T3 (es) | 2013-05-03 |
NZ575635A (en) | 2011-08-26 |
BRPI0716550A2 (pt) | 2013-09-24 |
ZA200901988B (en) | 2010-06-30 |
CA2663234A1 (en) | 2008-03-20 |
EP2062884A1 (en) | 2009-05-27 |
US8148421B2 (en) | 2012-04-03 |
AU2007295510A1 (en) | 2008-03-20 |
US20100048666A1 (en) | 2010-02-25 |
CN101535289A (zh) | 2009-09-16 |
RU2009113546A (ru) | 2010-10-20 |
IL197506A0 (en) | 2009-12-24 |
EP2062884B1 (en) | 2013-02-20 |
MX2009002692A (es) | 2009-03-30 |
RU2414465C2 (ru) | 2011-03-20 |
TW200827343A (en) | 2008-07-01 |
AU2007295510B2 (en) | 2011-09-01 |
KR20090061034A (ko) | 2009-06-15 |
EP2062884A4 (en) | 2011-11-09 |
CN101535289B (zh) | 2013-06-05 |
CA2663234C (en) | 2014-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017214410A (ja) | ハロゲン置換へテロ環化合物 | |
KR20120080183A (ko) | 신규 페놀 유도체 | |
US20060194832A1 (en) | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | |
TWI233358B (en) | Preventive or recurrence-suppressive agents for liver cancer | |
JP6948680B2 (ja) | 代謝性疾患治療用化合物及びその製造方法、並びに応用 | |
WO2008032665A1 (fr) | Nouveau dérivé de l'acide phénylacétique | |
NO330528B1 (no) | Nye salter av benzazepinforbindelser, fremgangsmater for fremstilling derav, og anvendelse av slike i farmasoytiske sammensetninger | |
JPH10509140A (ja) | ピラゾール誘導体 | |
WO2001032658A1 (fr) | Compose de polyazanaphtalene et utilisation medicinale dudit compose | |
JPH06509110A (ja) | 胃及び十二指腸障害を治療する方法及び組成物並びに新規なpge↓2誘導体 | |
CN113387909A (zh) | 2,3-环氧丁二酰衍生物的医药用途 | |
JP2001504118A (ja) | Cox―2のインデン阻害剤 | |
CN114349665B (zh) | 二甲双胍焦谷氨酸晶体及其制备方法与应用 | |
BR112017019816B1 (pt) | Composto, composição farmacêutica, e seus usos | |
WO2022121222A1 (zh) | 吡啶巯乙酸类化合物及其制备方法、药学衍生物或配剂以及应用 | |
JP5476650B2 (ja) | 新規dif−1誘導体 | |
JP2001247461A (ja) | 糖尿病予防・改善剤 | |
WO2002036547A1 (fr) | Composes amides d'acide cyclopropanecarboxylique et utilisations medicales | |
JPH08151341A (ja) | スーパーオキシド産生阻害剤および1−ナフトール誘導体 | |
JPH03251588A (ja) | ケイ素置換アリルアミン誘導体 | |
WO2008052444A1 (fr) | Composés ayant un noyau hétérocyclique à six chaînons, leur procédé de fabrication et leur utilisation pharmaceutique | |
JPH04217679A (ja) | 置換アルキルアミン誘導体及びその用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780033734.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07828211 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008534321 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12009500438 Country of ref document: PH |
|
ENP | Entry into the national phase |
Ref document number: 2663234 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/002692 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 575635 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007295510 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007828211 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1906/CHENP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097007100 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2009113546 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2007295510 Country of ref document: AU Date of ref document: 20070910 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12440540 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0716550 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090310 |